Vanguard Capital Management
ORIC icon

Vanguard Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Vanguard Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.8M Buy
3,951,169
+264,162
+7% +$2.4M ﹤0.01% 2031
2026
Q1 		$46.7M Buy
+3,687,007
New +$41.9M ﹤0.01% 1888

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM

Vanguard Capital Management's ORIC Position: Q2 2026 in Review

Vanguard Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 7.2% in Q2 2026, buying an estimated $2.4M and bringing the position to 3,951,169 shares worth $42.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Vanguard Capital Management first reported a position in ORIC in Q1 2026 and has held it in 2 quarters since. The position peaked at $46.7M in Q1 2026. 179 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Vanguard Capital Management held 3,951,169 shares of Oric Pharmaceuticals worth $42.8M as of Q2 2026.
  • Vanguard Capital Management bought 264,162 Oric Pharmaceuticals shares in Q2 2026, an estimated $2.4M.
  • Oric Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2031 holding.
  • Vanguard Capital Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Oric Pharmaceuticals position peaked at $46.7M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.